Second and third line treatment in advanced non-small cell lung cancer.

Favaretto, Adolfo G; Pasello, Giulia; Magro, Cristina

Favaretto, Adolfo G; Pasello, Giulia; Magro, Cristina.

Affiliation

Favaretto AG; Oncologia Medica II, Istituto Oncologico Veneto IRCCS, Padova 35128, Italy. adolfo.favaretto@sanita.padova.it

Discov Med ; 8(43): 204-9, 2009 Dec.

Article in En | MEDLINE | ID: mdl-20040271

Subject(s)

Antineoplastic Agents/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Carboplatin/therapeutic use; Cisplatin/therapeutic use; Deoxycytidine/analogs & derivatives; Deoxycytidine/therapeutic use; Docetaxel; Drug Therapy, Combination; Glutamates/therapeutic use; Guanine/analogs & derivatives; Guanine/therapeutic use; Humans; Paclitaxel/therapeutic use; Pemetrexed; Taxoids/therapeutic use; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Discov Med Year: 2009 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links